Projects per year
Search results
-
Active
A MULTICENTER, OPEN-LABEL, PHASE 1B STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SULBACTAM-DURLOBACTAM IN HOSPITALIZED PEDIATRIC PATIENTS FROM BIRTH TO <18 YEARS WHO ARE RECEIVING SYSTEMIC ANTIBIOTIC THERAPY FOR SUSPECTED OR CONFIRM
Aigbivbalu, L. (PI)
Entasis Therapeutics ( Award # )
12/23/24 → 12/22/29
Project: Research project